![]() |
Volumn 7, Issue , 2002, Pages
|
Immunotherapy of human papillomavirus-associated malignancies and the challenges posed by T-cell tolerance.
a
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CANCER VACCINE;
CD137 ANTIGEN;
LEUKOCYTE ANTIGEN;
NERVE GROWTH FACTOR RECEPTOR;
TNFRSF9 PROTEIN, HUMAN;
TNFRSF9 PROTEIN, MOUSE;
TUMOR NECROSIS FACTOR RECEPTOR;
ANIMAL;
DENDRITIC CELL;
FEMALE;
HUMAN;
IMMUNOLOGICAL TOLERANCE;
IMMUNOLOGY;
LYMPHOCYTE ACTIVATION;
METABOLISM;
MOUSE;
PAPILLOMA VIRUS;
REVIEW;
T LYMPHOCYTE;
TRANSPLANTATION;
UTERINE CERVIX TUMOR;
VIROLOGY;
VIRUS INFECTION;
ANIMALS;
ANTIGENS, CD;
ANTIGENS, CD137;
CANCER VACCINES;
DENDRITIC CELLS;
FEMALE;
HUMANS;
IMMUNE TOLERANCE;
LYMPHOCYTE ACTIVATION;
MICE;
PAPILLOMAVIRIDAE;
PAPILLOMAVIRUS INFECTIONS;
RECEPTORS, NERVE GROWTH FACTOR;
RECEPTORS, TUMOR NECROSIS FACTOR;
T-LYMPHOCYTES;
TUMOR VIRUS INFECTIONS;
UTERINE CERVICAL NEOPLASMS;
|
EID: 0036548614
PISSN: None
EISSN: 10934715
Source Type: Journal
DOI: 10.2741/wilcox Document Type: Review |
Times cited : (7)
|
References (266)
|